Katya Losk, Senior Director of International Strategic Initiatives at Dana-Farber Cancer Institute, shared a post on LinkedIn:
“Proud to see Dana-Farber Cancer Institute represented at the WHX Dubai Oncology Track on Wednesday, February 11, at the Frontiers Stage. Please join us for insights from Dana-Farber’s leading experts, including Toni Choueiri, MD; Patrick Ott, MD, PhD; Leslie Lehmann, MD; Rizwan Romee, MD; and Praful Ravi, MB, BChir, MRCP.
Where to find Dana-Farber faculty on the agenda:
- 11:30-12:30 pm
New Frontiers in Cancer Care at Dana-Farber Cancer Institute: The Impact of Novel Therapies, Theranostics and Cancer Vaccines
Examining the latest innovations in oncology care and exploring frameworks that enable sustainable, high-impact international collaboration models in cancer research, education, and clinical practice.
Dana-Farber participants: Toni Choueiri, MD (Moderator) and panelists Patrick Ott, MD, PhD; Leslie Lehmann, MD; Rizwan Romee, MD; Praful Ravi, MB, BChir, MRCP
- 1:30-2:00 pm
From Trials to Transformation: How Clinical Research Can Power the UAE’s R&D Economy
Exploring how a maturing clinical trial ecosystem can position the UAE as a regional and global hub for biomedical innovation.
Dana-Farber participant: Leslie Lehmann, MD
- 2:30-3:00 pm
Transforming Cancer Care Through AI: Data, Decision-Making & Delivery
Exploring AI’s role across predictive analytics, digital pathology, imaging, and clinical decision support.
Dana-Farber participant: Toni Choueiri, MD
Visiting the Expo? Please stop by the Dana-Farber Cancer Institute booth in the USA Pavilion: S17.D71. We look forward to connecting with our colleagues from across the globe.”
More posts featuring Katya Losk.